Clinical trials

Every new treatment is usually tested in three phases of clinical trials before regulatory agencies consider it safe and effective.

All Roche clinical studies, no matter where they are conducted, are managed in compliance with international guidelines.

How we make clinical study reports available to qualified researchers for further scientific study.

Patient safety is a top priority. Find out how we optimise patient safety throughout the lifecycle of a medicine.

Some patients with serious or immediately life-threatening diseases may not be eligible for any clinical trials and may not have other options. Under specific circumstances and in compliance with applicable laws, we may provide patients with pre-approval access (PAA) to unapproved or investigational medicines outside the clinical trials process, before they are approved by regulatory authorities.

As we head further into the era of precision healthcare, new ways to evolve the drug development process are being explored. Here, we look at some of the latest approaches.

Join a digital community of survivors, care givers & health professionals around the world as we raise awareness about cancer clinical trials.